Archive for ‘India alert’

20/05/2013

* A robust defence of India’s growth story

English: Arvind Panagariya

English: Arvind Panagariya (Photo credit: Wikipedia)

FT: “Why Growth Matters: How Economic Growth In India Reduced Poverty and The Lessons For Other Developing Countries, by Jagdish Bhagwati and Arvind Panagariya, PublicAffairs, RRP$28.99/RRP£19.99

English: Jagdish Bhagwati

English: Jagdish Bhagwati (Photo credit: Wikipedia)

With an election due in 2014, India may soon face its most intriguing political choice in a generation. On one side stands Rahul Gandhi, the son of Congress party leader Sonia Gandhi, and scion of a dynasty stretching back to the nation’s independence in 1947. On the other is Narendra Modi from the Hindu nationalist Bharatiya Janata party opposition, a controversial but effective chief minister who runs the business-friendly state of Gujarat.

Both men have drawbacks. It is never clear Mr Gandhi actually wants the top job, while Mr Modi’s appeal is blemished by a massacre of Muslims that occurred on his watch in 2002. Nonetheless, the potential clash has New Delhi’s political class salivating; it could even offer something approaching a battle of ideas between the broadly centre-left Congress and the more centre-right Mr Modi.

Yet behind it lies the need for a deeper debate about the direction of the economy; a debate that is often poorly articulated by political leaders, even as India’s growth has lately come off the boil so conspicuously.

More

For that reason this latest contribution from Jagdish Bhagwati and Arvind Panagariya, two Indian-born economists at Columbia University, is welcome. In Why Growth Matters, the duo provide perhaps the most full-throated defence to date of India’s economic liberalisation, which began in 1991 and is widely understood to have led to a period of fast growth over the past decade.

But not so fast: leftwing critics are undermining these achievements, the authors claim, promulgating a series of “myths” that are debunked in the first half of the book. The result is a convincing (if at times slightly wearying) litany, arguing that India’s growth spurt did indeed benefit lower caste Indians, for instance, or that it lifted many millions of people from poverty.

It is notable for its pugnacious tone too; for this is a book that comes out swinging. In its early pages the economist Joseph Stiglitz and the financier George Soros are accused of “Jurassic Park economics”, for their questioning of pro-market orthodoxies. The work of Dani Rodrik, a respected Harvard academic who backs some trade restrictions in developing countries, is dismissed tartly as “hollow”.

The Indian thinker Amartya Sen is mentioned only in passing, however, which seems odd, given Why Growth Matters is in large part a riposte to his arguments – namely that post-reform India has suffered rising inequality and performed badly on development indicators, at least when compared to poorer neighbours such as Bangladesh and Nepal.

Indeed, Prof Bhagwati and Prof Sen have been staking out their sides of this debate for years, with the former styling himself as the chief defender of further liberalisation. It is a cause he clearly relishes, although one that would benefit from considering the unpopularity of the measures he backs. If the argument for further growth-enhancing liberalisation has only upsides, the reader is left to ponder why it often has so few allies.

Despite this, the authors’ contention that India needs a further shake-up is surely correct, as is their suggested focus on rejigging outdated systems of land acquisition, planning and a tightly regulated labour market.

The latter point is especially well made: India ought to be a global giant in low-skilled, labour-intensive manufacturing industries, such as garment-making and electronics. But it isn’t – in fact the country employs only about 5m workers in manufacturing facilities with more than 10 staff, a pitiful record in a country with about half a billion workers, but where senseless regulations stop too many businesses expanding.”

via A robust defence of India’s growth story – FT.com.

About these ads
19/05/2013

* China Premier Li Keqiang in India for first foreign trip

BBC: “China‘s Premier Li Keqiang is travelling to India in the first stop of his maiden foreign trip since taking office.

Chinese and Indian flags flie in New Delhi on 18 May 2013

Upon his arrival in Delhi, Premier Li will hold talks with Prime Minister Manmohan Singh, followed by dinner at the Indian leader’s residence.

Border tensions and trade ties are expected to be among the issues discussed by the two men.

The neighbours are the world’s two most populous countries.

Beijing hopes the visit will help build trust and a new strategic partnership to the benefit of both countries, China’s official news agency Xinhua said.

Delhi thought “very highly” of Mr Li’s decision to make India his first foreign stop and the aim of the talks was to “enhance trust”, Indian foreign ministry spokesman Syed Akbaruddin said.

A decades-long border dispute flared up last month after India accused Chinese troops of crossing the countries’ de facto border in the Himalayas.

The dispute over the territory in the Ladakh region has dogged the two countries since the 1950s.

Boosting trade ties is also expected to dominate the talks. China is already one of India’s top trading partners and both countries have already agreed a new $100bn (£65bn) bilateral trade target for 2015.

Premier Li will spend three days in India before travelling on to Pakistan, Switzerland and Germany.”

via BBC News – China Premier Li Keqiang in India for first foreign trip.

16/05/2013

* India: Patents and precedents

FT: “Pharmaceutical companies fear that the battle raging in India over patents will inspire other countries to change their laws

Meena, a 45-year-old New Delhi widow with a 10-year-old son, was diagnosed with potentially fatal blood cancer in 2010. To control it, her doctors prescribed an Indian*- made generic version of Novartis’ leukaemia drug.

But her body stopped responding to it and Meena was advised to switch to a more expensive drug, Sprycel, a second-line cancer drug made by Bristol-Myers Squibb. Sprycel costs Rs160,000 ($2,900) per month, far out of reach for a woman living on her late husband’s Rs17,000 monthly pension.

A solution appeared to be at hand last May when Natco, an Indian generic drugs company, started selling its own version of Sprycel for Rs9,000 a month. A charity helped Meena to buy it.

But Meena’s ability to obtain potentially lifesaving medicine became tied up in a dispute pitting the interests of the world’s largest drugmakers – who spend $70bn annually developing drugs – and generic manufacturers in the developing world.

BMS, the US drugs group with revenues of $17.6bn in 2012, accused Natco of patent infringement, prompting the India’s Supreme Court to order the Indian drugmaker to stop making the medicine until a final verdict was reached. While some patients stocked up before the generic disappeared, Meena could only afford a few bottles.

The BMS “access programme” for the poor offered to sell her Sprycel for Rs15,000 per month – a big discount on the market price but still more than she can afford. Friends have chipped in to buy her a month’s supply but she is distraught about the future. “I don’t see a ray of hope,” she says. “Even if I use all my resources, I can only afford it for two months. It’s not sustainable.”

It is this struggle of educated, middle-class patients to obtain cutting-edge medicine that has led to a showdown between India and western pharmaceutical companies over the patents and prices of lifesaving drugs.

Western drugmakers fear India will inspire other emerging markets to challenge their patents. They have accused India of trampling on their intellectual property rights after a series of decisions overriding, revoking or refusing patents on cancer and hepatitis C drugs from Bayer, Pfizer, Roche and Novartis. The companies are also irate that New Delhi is considering compulsory licenses for another three patented cancer drugs, including Sprycel, and Roche’s breast cancer drug Hercepterin.

At a recent US Congressional hearing, Roy Waldron, Pfizer’s chief intellectual property officer, complained that New Delhi had “routinely flouted trade rules to bolster the Indian generics industry”.

Indian generics executives and patients activists say the reality is more nuanced. They argue that India’s courts are trying to balance drug companies’ intellectual property rights against the need for affordable medicine for 1.2bn Indians. India’s public healthcare system has virtually collapsed, with Indians paying 60 per cent of their healthcare costs from their own pockets.

This stand-off is taking place within the framework of a new patent law crafted to preserve India’s manoeuvring room to keep medicines affordable at home – and protect its exports of drugs abroad.

“The portrayal is that India doesn’t respect intellectual property rights but the reality is that it is balanced,” says Leena Menghaney, a lawyer with Médecins Sans Frontières, the humanitarian organisation. “The decisions that go in favour of the MNCs [multinational corporations] never get reported and decisions against them always hit the headlines.”

D.G. Shah, secretary-general of the Indian Pharmaceutical Alliance, which represents India’s biggest generics firms, rejects suggestions of protectionism for domestic companies.

via India: Patents and precedents – FT.com.

15/05/2013

* Rotavirus: India unveils cheap Rotavac diarrhoea vaccine

Pharmaceuticals is one of India‘s advanced industries.

BBC: “Scientists in India have unveiled a new low-cost vaccine against a deadly virus that kills about half a million children around the world each year.File photo of Indian children suffering from diarrhoea

Rotavirus causes dehydration and severe diarrhoea and spreads through contaminated hands and surfaces and is rampant in Asia and Africa.

India says clinical trials show the new vaccine, Rotavac, can save the lives of thousands of children annually.

An Indian manufacturer said the vaccine would cost 54 rupees ($1; £0.65).

International pharmaceutical companies GlaxoSmithKline and Merck produce similar vaccines but each dose costs around 1,000 rupees.

“This is an important scientific breakthrough against rotavirus infections, the most severe and lethal cause of childhood diarrhoea, responsible for approximately 100,000 deaths of small children in India each year,” India’s Department of Biotechnology official K Vijay Raghavan said.

“The clinical results indicate that the vaccine, if licensed, could save the lives of thousands of children each year in India,” he added.

Rotavac will be made by Hyderabad-based Bharat Biotech. The company said it could mass-produce tens of millions of doses after clearance is given, expected in eight or nine months.”

via BBC News – Rotavirus: India unveils cheap Rotavac diarrhoea vaccine.

See also - http://chindia-alert.org/economic-factors/indias-services/

15/05/2013

* After ATM heist, India’s IT sector again in unwelcome spotlight

Reuters: “A breach of security at two payment card processing companies in India that led to heists at cash machines around the world has reopened questions on the risks of outsourcing sensitive financial services to the Asian nation.

The EnStage Inc. office is seen in the southern Indian city of Bangalore in this May 12, 2013 file photo. REUTERS/Stringer/Files

Global banks that ship work to be processed in India, either in-house or to big IT services vendors, were already under pressure to step up oversight of back-office functions after a series of scandals last year.

Last week, U.S. prosecutors said a global criminal gang stole $45 million from two Middle Eastern banks by breaking into the two card processing companies based in India and raising the balances and withdrawal limits.

“India is exposed in two ways: The threat that the same theft could happen in India and the fact that the outsourcing industry will also get affected,” said Arpinder Singh, partner and national director for fraud investigation and dispute services at consultancy Ernst & Young.

The episode is reopening debate on banks sending work requiring a high degree of confidentiality to offshore locations.

“It is the weakest link,” said Shane Shook, an expert with U.S. cyber-security firm Cylance Inc who has helped financial firms conduct investigations into some major cyber crimes.

“I think the lesson is they need to pull back on what they’ve outsourced. When you’re giving a third party, the outsourced entity, the ability to access credit limits or cash limits of the consumers you’re managing the finances for, you’re giving up control that is your fundamental responsibility.”

India’s $108 billion IT services industry is the world’s favored destination for outsourcing. Over 40 percent of exports by the industry are support services for the global financial sector, ranging from investment bank back-office functions to research, risk-management and processing of insurance claims.”

via After ATM heist, India’s IT sector again in unwelcome spotlight | Reuters.

15/05/2013

* How India’s buses got connected

FT: “Phanindra Sama remembers only too clearly the inspiration behind his business. “RedBus was started because of a personal pain point,” he says. “I couldn’t get a bus ticket.”

Phanindra Soma CEO of RedBus photographed in a bus in Bangalore, India on Friday, May 10, 2013

It was October 2005 and Mr Sama, who is known to everyone in his company simply as “Phani”, was heading home to celebrate Diwali, the Hindu festival of lights. The journey involved a trip from Bangalore to his parents’ home near Hyderabad, nearly 600km to the north.

“I went to this travel agent to book a ticket. He made a few phone calls to the bus operators and told me there were no seats,” says Mr Sama. He tried four more agents. All called a couple of bus companies, but none could find a seat. Even more frustrating, all of the agents told him there might be a ticket out there – they just couldn’t locate it.

Mr Sama was stuck. “I am there, all flustered, staying in my flat,” he says of the long holiday weekend that followed. “I woke up the next day, and all of my friends were not there because they had gone home. It really pained me.”

An electronics engineer by training and working for Texas Instruments, he decided to do something about it. The result was RedBus, India’s leading bus ticketing service, which links thousands of unconnected bus operators and ticket agents, and sold more than 7.5m tickets last year.

Mr Sama’s entrepreneurial journey required figuring out India’s vast but fragmented $3bn bus system, which is dominated by small and often unreliable operators. Buses often leave from anonymous storefronts and frequently travel overnight. While some are upmarket, modern vehicles with wireless internet and air conditioning, most offer much more basic features.

When Mr Sama entered the industry, fast economic growth and urbanisation had vastly increased demand for travel. But most people couldn’t afford to fly and India’s celebrated train system struggled to cope with rising demand.

A lesson in listening

Phanindra Sama says being an entrepreneur has taught him a lot about listening. Speaking of the bus operators who have received bad reviews on RedBus, he says: “You get these calls from people saying: ‘I’ve been in the industry for 10 years and suddenly you come and rate me as a bad operator. What about my reputation?’ ”

“I think a lot of entrepreneurs probably don’t make time. If somebody says, ‘I want to talk to you’, they don’t make time,” he says. “We make time because that is very important for us.”

It is a lesson he has picked up not only from patiently listening to angry customers but also from reading management theory.

“There is a common theme in all those books. They say make space for others,” he explains. “I have dreams and passions, [but] everybody in the team also has their own dreams and passions. So if I have to get the best progress that we want, it can’t just be me standing there and having everybody do what I want.”

Even so, Mr Sama found India’s bus users were treated shabbily, with scant information on prices or bus companies. “This whole industry was very unregulated,” he says – a situation he admits has barely changed in the years since the company’s launch.

Despite holding down a day job, Mr Sama spent his weekends working out how to improve matters and even convinced his two flatmates to join him. Just under a year later, the trio had quit their jobs and were preparing to launch the RedBus website, along with two other software packages linking India’s disparate travel agents and bus companies.

The site has since become both popular and profitable, with revenues of Rs6bn ($110m) last year. It has also won fresh funding from the likes of Inventus Capital and Helion Venture Partners, investors attracted by an Indian intercity bus industry with revenues projected to grow to about $8bn over the next four years.”

via How India’s buses got connected – FT.com.

15/05/2013

* Companies turn to India to boost their business

FT: “Oil company Shell’s technology centre in the Indian high-tech hub of Bangalore is actually a facility in two halves, with a couple of campuses in different locations around the city.

Originally unable to find one suitable site for its growing efforts, the Anglo-Dutch company decided to split the difference, setting up dual facilities, working on everything from next-generation chemicals to underwater modelling.

But now the company plans to bring everything back together, having announced plans late last year to build a giant new research and development campus on a patch of land close to Bangalore’s airport, with room for 1,500 staff, and even plans for a cricket pitch on the grounds.

Shell’s move is part of a pattern in which many of world’s largest companies are turning to India in their search for new ideas that will boost its business, and follows similar moves to open up innovation facilities around Bangalore by the likes of GE, Cisco and Siemens.”

via Companies turn to India to boost their business – FT.com.

14/05/2013

* Britain launches ‘super priority’ same-day visa service for Indians

Times of India: “Britain on Tuesday rolled out the same-day visa for Indians, making it the first country to get a visa to visit UK within 24 hours.

Taj Mahal, Agra, India. Deutsch: Taj Mahal im ...

Taj Mahal, Agra, India. Deutsch: Taj Mahal im indischen Agra. Español: Vista del Taj Mahal, Agra, India. Français : Le Taj Mahal, à Âgrâ, en Inde. Русский: Мавзолей Тадж-Махал, Агра, Индия. (Photo credit: Wikipedia)

The same-day visa service was announced by British prime minister David Cameron during his recent visit to India.

However, it comes with a fat price – it will cost £600 (nearly Rs 50,000) in addition to the price of the visa.

Those in Delhi and Mumbai will be able to apply for this service.

The UK home ministry said the ‘super priority’ visa is the first-of-its-kind to be launched ever and there are plans to expand the scheme to Chennai in the next few weeks.

Immigration minister Mark Harper said “this government is committed to encouraging international business to invest in Britain. India and Britain have a long history of trade and we run our largest visa operation in the world there. We are delighted to be able to launch our first same-day visa service in Delhi and Mumbai, and make our world class visa service even better.”

UK home office added that the service will be available to those who are applying for a six-month or two-year multiple entry visitor visa (excluding student visit visas) and have travelled without difficulty in the last five years to one of the following countries – UK, US, Australia, New Zealand, Canada or a Schengen country. Those who are employees of companies that are members of the Business Express Programme (managed by UK Trade and Investment in India) and are travelling as an official business visitor will also be able to apply.

The Home office added “We strongly recommend that customers with any form of adverse immigration history do not use this service. Using the super priority visa service does not imply or guarantee in any way that your visa application will be successful. All applicants must meet the requirements of the UK’s immigration rules.”"

via Britain launches ‘super priority’ same-day visa service for Indians – The Times of India.

14/05/2013

* India and China; making up, but what about trade?

FT: “Salman Khurshid, India’s foreign minister, is back from a trip to China last week, happy to see the end of a tense stand-off over a long-running border dispute. Settling that issue will re-open the way for a planned visit by Chinese Premier Li Keqiang to India and allow the two countries to concentrate on the big topic on Khurshid’s agenda: trade.

But here, too, relations between the region’s big powers are not entirely friendly.

Back in November 2011, India and China set a target for bilateral trade of $100bn for 2015. That’s quite a leap from $2.3bn a decade ago and marks a concrete step in bringing the two nations closer together.

But the balance of trade is strongly in China’s favour. Now Kurshid has put the November 2011 agreement “on pause” until the imbalance is resolved.

According to India’s department of commerce, India’s exports to China in April to December 2012 were worth $9.7bn. In the same period, China’s exports to India were worth $41.2bn – a bilateral trade deficit for India of $31.5bn, nearly a quarter of India’s entire trade deficit in the period.

Khurshid claimed not to have minced his words:

We said that let the trade imbalance be addressed upfront as an urgent priority, and then of course we can move to the next stage which is the regional trading arrangement.

What does the minister want from China? One target is better market access, especially for India’s IT and pharmaceuticals companies. Indian business leaders complain that exports to China would be much greater if China’s big state owned enterprises could be persuaded to source from foreign suppliers.

But others say a lack of competitiveness among Indian manufacturers contributes to the problem.

“China has a very competitive manufacturing sector that is able to produce at a large scale pretty efficiently and for reasonable prices,” says Louis Kuijs, chief China economist at RBS.

“Sometimes we would be inclined to think there is a lot of [Chinese] government policy behind this. People point to the subsidies that China’s government has given to industries in the past and companies having preferential access to loans. But in the bigger scheme of things, those subsidies aren’t the driving force. China is a bit ahead in industrialisation and has becomes very competitive globally.”

Kuijs doesn’t think this is about to change. Chinese manufacturers do good business in India in both consumer goods and capital goods. And he takes the view that, despite the current cyclical slowdown, both consumption and infrastructure investment will remain robust in India, so demand for Chinese products will continue to grow.

A little tinkering on a calculator provides a bit of good news for Indian trade, however. According to data from the World Trade Organization, India’s global merchandise exports grew faster than China’s between 2005 and 2012. Over the seven-year period, India’s exports grew at an average 18.3 per cent a year, against a figure of 16.3 per cent for China and 9.4 per cent for the world as a whole.

So, Indian exports are growing relatively quickly. But China’s lower growth comes from a far higher base. In 2012, China exported goods worth more than $2tn while India’s exports were worth $293bn. Even with their faster rate of growth, it will take a long time for India’s exporters to catch up on China’s lead.”

via India and China; making up, but what about trade? | beyondbrics.

11/05/2013

* U.S., European Auto Makers Find Slow Going in India

WSJ: “Sleek new compact cars sporting the Maruti Suzuki and Hyundai brands stand out on the streets of India’s business capital against the mishmash of aging buses and black taxicabs.

image

The view is similar across India, a country where consumers have an affinity for smaller and fuel-efficient cars and, increasingly, for Asian auto brands. Much harder to spot are the logos of top Western mass-market car makers such as Volkswagen AG, VOW3.XE -0.88% General Motors Co. GM -0.73% and Ford Motor Co. F -0.63%

Profit margins are thin in India, where hatchbacks sell for as low as $5,000. Maruti and Hyundai together hold 54% of the nation’s new-car sales.

While major players in China, Asia’s other big and growing car market, the three are struggling to expand sales here. Each reported Indian sales fell between 16% and 20% year-over-year in the 12 months ended March, sharply underperforming the 2.2% rise among all passenger vehicle sales in the nation, according to data from the Society of Indian Automobile Manufacturers. Their combined share of the car market stands at just 9%.

Some industry executives say these companies lack the compact models that consumers prefer in India, and have too few sales and repair outlets in the country.

Others say razor-thin profit margins on small cars make India a highly competitive and unprofitable market, and may explain the Western companies’ small shares. India’s compact hatchbacks usually sell for between $5,000 and $10,000 each.

“It isn’t that the international companies are incompetent, it is just that there is not much of a prize [in India] yet. It is a much, much smaller profit pool,” compared with markets like China, said Max Warburton, European and Asian autos analyst at investment research firm Sanford C. Bernstein & Co.

Maruti, the Indian unit of Japan’s Suzuki Motor Co., 7269.TO +7.53% and Hyundai Motor Co 005380.SE -2.33% . together hold 54% of the nation’s new-car sales, thanks to a broad sales and service networks and a loyal following for their cars and hatchbacks, which last year took seven spots out of the 10 best-selling models in India.

Japan-based Honda Motor Co. 7267.TO +3.18% and Toyota Motor Corp. 7203.TO +5.03% also are gaining here despite the overall market’s stagnant sales following several boom years. Asian-brand cars account for around 64% of the nation’s market.

Meanwhile, Volkswagen hasn’t launched a new compact model in India since 2010, save for refreshed versions of existing cars, while Ford launched just one, the new Fiesta, in 2011. GM launched its Sail U-VA last November.”

via U.S., European Auto Makers Find Slow Going in India – WSJ.com.

Follow

Get every new post delivered to your Inbox.

Join 157 other followers